Gregory Grunberg - Profile and Investment Details

Find investors who align with your industry, stage, and vision. Unlock Gregory Grunberg’s full investment profile, including location, investment focus, portfolio companies, and preferences. Sign up today and start building investor relationships that fuel your startup’s growth.

Get connected with all investors today
Investor type
Country
City/Area
Stages

-

Contacts
Emailfir***@***.com Available after registration.
Markets
Past investments
CorticaZavante TherapeuticsCardioDxWelbeHealthVelicept TherapeuticsEsperion TherapeuticsAptus EndosystemsLongitude CapitalCydanJazz PharmaceuticalsEargoOrbus TherapeuticsLEXEO TherapeuticsRxSightAqueSys, IncInfaCare PharmaceuticalAptinyxSomatusTalaris TherapeuticsKaNDy TherapeuticsSARcode Bioscience Inc.DascenaCohere HealthVenus ConceptEpirium Bio89bio [Ticker: ETNB]Axonics Modulation TechnologiesTricidaPractice FusionAmphora MedicalNeurana PharmaceuticalsCollegium PharmaceuticalSublimity TherapeuticsRapid Micro BiosystemsVelomedixPolares MedicalPixelOpticsSydnexisOn Belay Health SolutionsVera TherapeuticsCheckmate PharmaceuticalsVaxcyteCuraSen TherapeuticsCivitas TherapeuticsSolta MedicalCalifornia Cryobank LLCAlphaeonAmunixBAROnovaPoseida TherapeuticsMolecular TemplatesHelomicsNOCDSympara MedicalPreCision DermatologyTiburio TherapeuticsCorcept TherapeuticsAimmune TherapeuticsMURJ89bioInozymeAqueSysPHT CorporationKala PharmaceuticalsEncore DermatologyWhitehill TechnologiesEndeavor BioMedicines
Investor Profile

Gregory Grunberg is a Venture Capital based in Menlo Park, California, United States with a diverse investment portfolio that includes companies such as Cortica, Zavante Therapeutics, CardioDx, WelbeHealth, Velicept Therapeutics, Esperion Therapeutics, Aptus Endosystems, Longitude Capital, Cydan, Jazz Pharmaceuticals, Eargo, Orbus Therapeutics, LEXEO Therapeutics, RxSight, AqueSys, Inc, InfaCare Pharmaceutical, Aptinyx, Somatus, Talaris Therapeutics, KaNDy Therapeutics, SARcode Bioscience Inc., Dascena, Cohere Health, Venus Concept, Epirium Bio, 89bio [Ticker: ETNB], Axonics Modulation Technologies, Tricida, Practice Fusion, Amphora Medical, Neurana Pharmaceuticals, Collegium Pharmaceutical, Sublimity Therapeutics, Rapid Micro Biosystems, Velomedix, Polares Medical, PixelOptics, Sydnexis, On Belay Health Solutions, Vera Therapeutics, Checkmate Pharmaceuticals, Vaxcyte, CuraSen Therapeutics, Civitas Therapeutics, Solta Medical, California Cryobank LLC, Alphaeon, Amunix, BAROnova, Poseida Therapeutics, Molecular Templates, Helomics, NOCD, Sympara Medical, PreCision Dermatology, Tiburio TherapeuticsCorcept Therapeutics, Aimmune Therapeutics, MURJ, 89bio, Inozyme, AqueSys, PHT Corporation, Kala Pharmaceuticals, Encore Dermatology, Whitehill Technologies, Endeavor BioMedicines, . Over time, Gregory Grunberg has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Gregory Grunberg is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Wearables, Women Founded, Life Science, Information Technology (IT), Software, Biotechnology, Podcasts, Market Research, Consumer Software, Health Diagnostics, Developer Tools, Travel, Medical, Therapeutics, Pharmaceuticals may find it worthwhile to explore potential connections with Gregory Grunberg, as their portfolio suggests a familiarity and interest in this area.

Understanding Gregory Grunberg’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.

Finally raise your round with Angel Match

Angel Match is the easiest way to research investors for your startup so you can spend less time Googling and more time raising.

Find the perfect investors today